Grail’s cancer blood test shows ‘proof of principle,’ but challenges remain

Will Grail hit its its out-of-the-park goal of detecting tumors super-early with a blood test? The early results are in for its liquid biopsy.

More From BioPortfolio on "Grail’s cancer blood test shows ‘proof of principle,’ but challenges remain"